非小细胞肺癌的辅助化疗：它并非总是随时间而消退。 - Suppr

Adjuvant chemotherapy for non-small-cell lung cancer: it does not always fade with time.

作者信息

Douillard Jean-Yves

出版信息

J Clin Oncol. 2010 Jan 1;28(1):3-5. doi: 10.1200/JCO.2009.25.5109. Epub 2009 Nov 23.

DOI:10.1200/JCO.2009.25.5109

PMID:19933901

Abstract

摘要

相似文献

Adjuvant chemotherapy for non-small-cell lung cancer: it does not always fade with time.

J Clin Oncol. 2010 Jan 1;28(1):3-5. doi: 10.1200/JCO.2009.25.5109. Epub 2009 Nov 23.

[Adjuvant chemotherapy in non-small-cell lung cancer: proven survival benefit].

Pneumologie. 2004 Jun;58(6):393-4. doi: 10.1055/s-2004-818500.

Chemotherapy helps patients with advanced non-small cell carcinoma of the lung.

N C Med J. 1996 Sep-Oct;57(5):281-6.

[Postoperative adjuvant treatment for non-small cell lung cancer].

Gan To Kagaku Ryoho. 2002 Dec;29(13):2470-4.

The current status of adjuvant chemotherapy for resected non-small cell lung cancer.

Semin Oncol. 1999 Oct;26(5 Suppl 15):27-33.

Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer.

Lung Cancer. 2008 Jun;60(3):434-40. doi: 10.1016/j.lungcan.2007.10.013. Epub 2007 Nov 26.

[Bronchial cancer--adjuvant chemotherapy].

Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1990:89-94.

[Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].

Gan To Kagaku Ryoho. 2006 Mar;33(3):300-6.

Adjuvant chemotherapy in resected non-small cell lung cancer.

Rays. 2004 Oct-Dec;29(4):435-7.

[Adjuvant chemotherapy for non-small cell lung cancer. WJSG: West Japan Study Group for Lung Cancer Surgery].

Gan To Kagaku Ryoho. 1994 Oct;21 Suppl 3:356-61.

引用本文的文献

HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer.

J Cancer Res Clin Oncol. 2014 Aug;140(8):1441-9. doi: 10.1007/s00432-014-1687-2. Epub 2014 Apr 27.

High expression of a disintegrin and metalloproteinase-9 predicts a shortened survival time in completely resected stage I non-small cell lung cancer.

Oncol Lett. 2013 May;5(5):1461-1466. doi: 10.3892/ol.2013.1209. Epub 2013 Feb 22.

Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumors.

Cancer Treat Rev. 2013 Feb;39(1):27-43. doi: 10.1016/j.ctrv.2012.03.007. Epub 2012 Apr 19.

Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research.

J Exp Clin Cancer Res. 2011 Dec 29;30(1):115. doi: 10.1186/1756-9966-30-115.

[Aberrant expression of HDGF and its prognostic values in surgically resected non-small cell lung cancer].

Zhongguo Fei Ai Za Zhi. 2011 Mar;14(3):211-8. doi: 10.3779/j.issn.1009-3419.2011.03.06.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Adjuvant chemotherapy for non-small-cell lung cancer: it does not always fade with time.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献